Navigation Links
Cell Therapeutics, Inc. (CTI) to Present at 10th Annual BIO Investor Forum
Date:10/18/2011

SEATTLE, Oct. 19, 2011 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) management will present at the 10th Annual BIO Investor Forum on Tuesday, October 25th at 11:30 a.m. Pacific/ 2:30 p.m. Eastern/ 8:30 p.m. Central European time in the Presidio Room of the Palace Hotel in San Francisco.

The presentation will also be webcast live with slides, and available for replay after the presentation. The webcast can be accessed at www.celltherapeutics.com.

BIO Investor Forum
CTI Presentation: Tuesday, October 25th, 2011
11:30 a.m. Pacific/ 2:30 p.m. Eastern/ 8:30 p.m. Central European
Presidio Room, Palace Hotel
Audio webcast with slides at www.celltherapeutics.com Media Contact:Investors Contact:Cell Therapeutics, Inc.Cell Therapeutics, Inc.Dan Eramian

Ed BellT: 206.272.4343

T: 206.272.4345F: 206.272.4434

Lindsey Jesch LoganE: media@ctiseattle.com

T: 206.272.4347www.celltherapeutics.com/press_room

F: 206.272.4434E: invest@ctiseattle.comwww.celltherapeutics.com/investors
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
2. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
3. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
4. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
5. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
6. Ocera Therapeutics, Inc. Completes Enrollment in FHAST1, a Pivotal Phase 3 Clinical Trial in Fistulizing Crohns Disease
7. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
8. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
9. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
10. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
11. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... Research and Markets has announced the addition of the ... to their offering. ... The global CINV drugs market to grow at a CAGR ... Surgery Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. To calculate ...
(Date:1/18/2017)... 17, 2017  With an annual growth ranging from 6% to 10%, ... (Jakarta International Expo, March 22-24, 2017) serves the industry by fostering the regional ... SEA 2017? Investment Forum ASEAN -- ... Richer conference content Enhanced business matchmaking program ... ...
(Date:1/18/2017)... ANTONIO , Jan. 18, 2017   Seno ... process of diagnosing breast cancer through the development of ... of Steve Miller as SVP of Engineering. ... Product Realization at FUJIFILM SonoSite, with headquarters in ... the majority of his 30-year career to the development ...
Breaking Medicine Technology:
(Date:1/18/2017)... ... January 18, 2017 , ... Michael J. Hennessy ... for its Center for Biosimilars, announced Michael J. Hennessy Associates, Inc. President Michael ... field of biosimilars through thought leader interaction in, live video and interactive digital ...
(Date:1/17/2017)... ... January 17, 2017 , ... January is National Stalking Awareness Month (NSAM), now in ... the corners and commit the crime of stalking, a very real danger to many in ... overlooked factor in stalking and other crimes. , “Stalking: know it. Name it. Stop it.”—so ...
(Date:1/17/2017)... , ... January 17, 2017 , ... ... the political/social/economic events, Dr. Carol Francis re-releases powerfully uplifting interview with medical expert ... that help everyone endure and pass through tough times, Dr. Bernie Siegel energizes ...
(Date:1/17/2017)... Chapel, Florida (PRWEB) , ... January 17, 2017 ... ... Connected City, a new 21st century approach to infusing high speed technology into ... an area exclusively dedicated to the advancement of healthcare and wellness in a ...
(Date:1/17/2017)... ... January 17, 2017 , ... Surgeons from New ... eye care practitioners on the latest breakthroughs in the prevention, diagnosis and treatment ... Symposium, according to eye surgeon, Jeffrey Martin, MD, FACS, Chief Executive Officer of ...
Breaking Medicine News(10 mins):